Fig. 1From: Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancerQTc interval values before and 6 months after the last trastuzumab (left)/trastuzumab emtansine cycle (right)Back to article page